Ulm, Germany

Markus Frank

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 4.7

ph-index = 5

Forward Citations = 108(Granted Patents)


Location History:

  • Ingelheim am Rhein, DE (2012)
  • Ulm, DE (2014 - 2023)

Company Filing History:


Years Active: 2012-2023

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Journey of Markus Frank in Pharmaceutical Patents

Introduction

Markus Frank is a notable inventor based in Ulm, Germany, recognized for his significant contributions to the field of pharmaceuticals. With a total of eight patents to his name, he has made strides in developing pharmaceutical solutions that address critical health challenges, particularly in oncology.

Latest Patents

Among his latest innovations are two groundbreaking patents. The first, entitled "Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors," encompasses compounds designed to inhibit the SOS1 protein. This invention details pharmaceutical compositions that utilize these compounds for the treatment and prevention of oncological diseases. The second patent focuses on "Co-crystals and salts of CCR3-inhibitors," which relates to new formulations for CCR3 inhibitors that can be applied as pharmaceutical agents for diseases associated with the CCR3 receptor. Both patents demonstrate Markus's commitment to advancing medical therapies.

Career Highlights

Markus Frank currently works with Boehringer Ingelheim International GmbH, a globally recognized pharmaceutical company. Throughout his career, he has been dedicated to researching and developing innovative solutions that enhance treatment efficacy. His work is instrumental in transforming scientific breakthroughs into practical medical applications, ensuring improved patient outcomes.

Collaborations

In his pursuit of innovation, Markus collaborates with talented professionals in the field. Notably, he works alongside Waldemar F Pfrengle and Marco Santagostino, both of whom contribute valuable insights and expertise. Their collective knowledge fosters an environment ripe for creative solutions in pharmaceutical research and development.

Conclusion

Markus Frank exemplifies the spirit of innovation within the pharmaceutical industry. Through his numerous patents and collaborative efforts, he is making significant strides in the development of treatments for critical diseases. His work continues to inspire advancements in medical science, showcasing the vital role inventors play in enhancing healthcare worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…